Economics of vaccines (English Wikipedia)

Kazaz, Burak; Webster, Scott; Yadav, Prashant (26 March 2021). "Incentivizing COVID-19 Vaccine Developers to Expand Manufacturing Capacity". Center for Global Development. Retrieved 5 October 2024.

dailyguidenetwork.com

Okertchiri, Jamila Akweley (30 November 2022). "National Vaccine Institute Nears Completion". DailyGuide Network. Retrieved 5 October 2024.

deanbaker.net

Dean Baker (2016), Rigged: How globalization and the rules to the modern economy were structured to make the rich richer, Center for Economic and Policy Research, Wikidata Q100216001.

doctorswithoutborders.org

"Pneumococcal Vaccine is Launched in Africa, But Are Donors Getting a Fair Deal from Companies?". Doctors Without Borders - USA.
"Vaccination". Doctors Without Borders - USA.

doi.org

Olesen OF, Lonnroth A, Mulligan B (January 2009). "Human vaccine research in the European Union". Vaccine. 27 (5): 640–5. doi:10.1016/j.vaccine.2008.11.064. PMC 7115654. PMID 19059446.
Jit M, Newall AT, Beutels P (April 2013). "Key issues for estimating the impact and cost-effectiveness of seasonal influenza vaccination strategies". Human Vaccines & Immunotherapeutics. 9 (4): 834–40. doi:10.4161/hv.23637. PMC 3903903. PMID 23357859.
Newall AT, Reyes JF, Wood JG, McIntyre P, Menzies R, Beutels P (February 2014). "Economic evaluations of implemented vaccination programmes: key methodological challenges in retrospective analyses". Vaccine. 32 (7): 759–65. doi:10.1016/j.vaccine.2013.11.067. PMID 24295806.
Vaillancourt, R (May 2012). "Drug shortages: what can hospital pharmacists do?". The Canadian Journal of Hospital Pharmacy. 65 (3): 175–9. doi:10.4212/cjhp.v65i3.1138. PMC 3379822. PMID 22783027.
Stanley A. Plotkin; Adel A.F. Mahmoud; Jeremy Farrar (23 July 2015). "Establishing a Global Vaccine-Development Fund" (PDF). The New England Journal of Medicine. 373 (4): 297–300. doi:10.1056/NEJMp1506820. PMID 26200974.
Storeng, Katerini T. (14 September 2014). "The GAVI Alliance and the 'Gates approach' to health system strengthening". Global Public Health. 9 (8): 865–879. doi:10.1080/17441692.2014.940362. ISSN 1744-1692. PMC 4166931. PMID 25156323.

hhs.gov

Goodman JL (2005-05-04). "Statement by Jesse L. Goodman, M.D., M.P.H. Director Center for Biologics, Evaluation and Research Food and Drug Administration U.S. Department of Health and Human Services on US Influenza Vaccine Supply and Preparations for the Upcoming Influenza Season before Subcommittee on Oversight and Investigations Committee on Energy and Commerce United States House of Representatives". Archived from the original on 2008-09-21. Retrieved 2008-06-15.
Stanley A. Plotkin; Adel A.F. Mahmoud; Jeremy Farrar (23 July 2015). "Establishing a Global Vaccine-Development Fund" (PDF). The New England Journal of Medicine. 373 (4): 297–300. doi:10.1056/NEJMp1506820. PMID 26200974.

msf.org

"GAVI money welcome but could it be more wisely spent?". Médecins Sans Frontières (MSF) International.
MSF. "Pfizer and GSK should not get huge subsidy for pneumonia vaccine". Médecins Sans Frontières (MSF) International.

msfaccess.org

"The Right Shot: Bringing down barriers to affordable and adapted vaccines - 2nd Ed., 2015". Médecins Sans Frontières Access Campaign. 20 January 2015.
"MSF's response to CEPI's policy regarding equitable access". Médecins Sans Frontières Access Campaign. 25 September 2018.
"Norway has invested 200 million euros in epidemic preparedness, but are they getting what they're paying for?". Médecins Sans Frontières Access Campaign. 7 March 2019.

newyorker.com

Vara, Vauhini. "Billions and Billions for Botox". The New Yorker.

nih.gov

pubmed.ncbi.nlm.nih.gov

Olesen OF, Lonnroth A, Mulligan B (January 2009). "Human vaccine research in the European Union". Vaccine. 27 (5): 640–5. doi:10.1016/j.vaccine.2008.11.064. PMC 7115654. PMID 19059446.
Jit M, Newall AT, Beutels P (April 2013). "Key issues for estimating the impact and cost-effectiveness of seasonal influenza vaccination strategies". Human Vaccines & Immunotherapeutics. 9 (4): 834–40. doi:10.4161/hv.23637. PMC 3903903. PMID 23357859.
Newall AT, Reyes JF, Wood JG, McIntyre P, Menzies R, Beutels P (February 2014). "Economic evaluations of implemented vaccination programmes: key methodological challenges in retrospective analyses". Vaccine. 32 (7): 759–65. doi:10.1016/j.vaccine.2013.11.067. PMID 24295806.
Vaillancourt, R (May 2012). "Drug shortages: what can hospital pharmacists do?". The Canadian Journal of Hospital Pharmacy. 65 (3): 175–9. doi:10.4212/cjhp.v65i3.1138. PMC 3379822. PMID 22783027.
Stanley A. Plotkin; Adel A.F. Mahmoud; Jeremy Farrar (23 July 2015). "Establishing a Global Vaccine-Development Fund" (PDF). The New England Journal of Medicine. 373 (4): 297–300. doi:10.1056/NEJMp1506820. PMID 26200974.
Storeng, Katerini T. (14 September 2014). "The GAVI Alliance and the 'Gates approach' to health system strengthening". Global Public Health. 9 (8): 865–879. doi:10.1080/17441692.2014.940362. ISSN 1744-1692. PMC 4166931. PMID 25156323.

ncbi.nlm.nih.gov

Olesen OF, Lonnroth A, Mulligan B (January 2009). "Human vaccine research in the European Union". Vaccine. 27 (5): 640–5. doi:10.1016/j.vaccine.2008.11.064. PMC 7115654. PMID 19059446.
Jit M, Newall AT, Beutels P (April 2013). "Key issues for estimating the impact and cost-effectiveness of seasonal influenza vaccination strategies". Human Vaccines & Immunotherapeutics. 9 (4): 834–40. doi:10.4161/hv.23637. PMC 3903903. PMID 23357859.
Vaillancourt, R (May 2012). "Drug shortages: what can hospital pharmacists do?". The Canadian Journal of Hospital Pharmacy. 65 (3): 175–9. doi:10.4212/cjhp.v65i3.1138. PMC 3379822. PMID 22783027.
Storeng, Katerini T. (14 September 2014). "The GAVI Alliance and the 'Gates approach' to health system strengthening". Global Public Health. 9 (8): 865–879. doi:10.1080/17441692.2014.940362. ISSN 1744-1692. PMC 4166931. PMID 25156323.

nytimes.com

Mazzucato, Mariana; Momenghalibaf, Azzi (18 March 2020). "Drug Companies Will Make a Killing From Coronavirus". The New York Times.
Gerald Posner (2 March 2020). "Big Pharma May Pose an Obstacle to Vaccine Development". New York Times. Retrieved 8 March 2020. Drug companies on CEPI's scientific advisory panel, including Johnson & Johnson, Pfizer, and Japan's Takeda, pushed back. CEPI mostly capitulated in a December 2018 two-page declaration in which it jettisoned specifics but gave lip service to its founding mission of "equitable access to these vaccines for affected populations during outbreaks."
Mazzucato, Mariana; Momenghalibaf, Azzi (18 March 2020). "Drug Companies Will Make a Killing From Coronavirus". The New York Times.
Lazonick, William; Tulum, Öner (26 February 2019). "How High Drug Prices Inflate C.E.O.s' Pay". The New York Times.

researchprofessionalnews.com

Tatalović, Mićo (29 March 2022). "In focus: has the UK's vaccine capacity improved?". Research Professional News. Retrieved 5 October 2024.

statnews.com

"Analysis: Large pharma companies do little new drug innovation". STAT. 10 December 2019.

supplychaindive.com

Patrick, Kate. "FDA commissioner decries drug industry oligopoly". Supply Chain Dive.

telegraph.co.uk

Field, Matthew; Boland, Hannah (21 March 2020). "UK in race for national vaccine facility after 'faffing around' on £66m project". The Telegraph. Retrieved 5 October 2024.

theairnet.org

Tulum, Öner; Lazonick, William (February 2019). "FINANCIALIZED CORPORATIONS IN A NATIONAL INNOVATION SYSTEM: THE US PHARMACEUTICAL INDUSTRY" (PDF). International Journal of Political Economy.

theatlantic.com

Hamblin, James (14 October 2016). "Doctors Refused a Million Free Vaccines–to Make a Statement About the Pharmaceutical Industry". The Atlantic.

thechemicalengineer.com

"Poll: Engineers warn sale of UK vaccine centre risks health security and industry innovation". www.thechemicalengineer.com. Retrieved 5 October 2024.

theguardian.com

Buranyi, Stephen (4 March 2020). "How profit makes the fight for a coronavirus vaccine harder". The Guardian.

theintercept.com

Lerner, Sharon (13 March 2020). "Big Pharma Prepares to Profit From the Coronavirus". The Intercept.

vox.com

Belluz, Julia (4 March 2020). "A guide to the vaccines and drugs that could fight coronavirus". Vox.

web.archive.org

Goodman JL (2005-05-04). "Statement by Jesse L. Goodman, M.D., M.P.H. Director Center for Biologics, Evaluation and Research Food and Drug Administration U.S. Department of Health and Human Services on US Influenza Vaccine Supply and Preparations for the Upcoming Influenza Season before Subcommittee on Oversight and Investigations Committee on Energy and Commerce United States House of Representatives". Archived from the original on 2008-09-21. Retrieved 2008-06-15.

who.int

Kaddar, Miloud. "Global Vaccine Market Features and Trends" (PDF). World Health Organization.
Røttingen, John-Arne (21 July 2017). "Coalition for Epidemic Preparedness Innovations (CEPI): Presentation to the WHO" (PDF). CEPI.

wikidata.org

Dean Baker (2016), Rigged: How globalization and the rules to the modern economy were structured to make the rich richer, Center for Economic and Policy Research, Wikidata Q100216001.

wikiversity.org

en.wikiversity.org

See also the 2021-02-23 interview with Baker in "v:Unrigging the media and the economy".

worldcat.org

search.worldcat.org

Storeng, Katerini T. (14 September 2014). "The GAVI Alliance and the 'Gates approach' to health system strengthening". Global Public Health. 9 (8): 865–879. doi:10.1080/17441692.2014.940362. ISSN 1744-1692. PMC 4166931. PMID 25156323.